This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "PDM-35" – news ·newspapers ·books ·scholar ·JSTOR(January 2017) (Learn how and when to remove this message)

3,5-dimethyl-2-phenylmorpholine (PDM-35)

Legal status
Legal status	CA: Unscheduled DE: NpSG (Industrial and scientific use only) UK: UnderPsychoactive Substances Act US: Analogue to aSchedule I/II drug
Identifiers
IUPAC name 3,5-dimethyl-2-phenylmorpholine
CAS Number	1218345-44-8
PubChemCID	43367115
DrugBank	Provide Please Provide
UNII	B5FRU2US8C
CompTox Dashboard(EPA)	DTXSID801342603
Provide&page2=PDM-35 (verify)

2-Phenyl-3,5-dimethylmorpholine is a drug withstimulant andanorectic effects, related tophenmetrazine. Based on what is known from other phenylmorpholines with similar structure, it likely acts as anorepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.^[1]

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• Anorectics
• Beta-Hydroxyamphetamines
• Phenylmorpholines
• Serotonin reuptake inhibitors
• Stimulants
• Nervous system drug stubs

• Articles with short description
• Short description matches Wikidata
• Articles needing additional references from January 2017
• All articles needing additional references
• Short description is different from Wikidata
• Infobox drug articles with non-default infobox title
• Articles without EBI source
• Chemical pages without ChemSpiderID
• Articles without KEGG source
• Articles without InChI source
• Drugs missing an ATC code
• All stub articles